TY - JOUR
T1 - Retransplantation for recurrent hepatitis C
T2 - Positive aspects
AU - McCashland, Timothy M.
PY - 2003/11
Y1 - 2003/11
N2 - Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.
AB - Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.
UR - http://www.scopus.com/inward/record.url?scp=0242456074&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242456074&partnerID=8YFLogxK
U2 - 10.1053/jlts.2003.50249
DO - 10.1053/jlts.2003.50249
M3 - Article
C2 - 14586899
AN - SCOPUS:0242456074
SN - 1527-6465
VL - 9
SP - S67-S72
JO - Liver Transplantation
JF - Liver Transplantation
IS - 11
ER -